$1B+ biopharma deals keep values afloat, even amid muted volume
Release Date:
BioWorld Senior Analyst Karen Carey chats about the collision of a volatile economic climate and big biopharma deals. Hosted on Acast. See acast.com/privacy for more information.
$1B+ biopharma deals keep values afloat, even amid muted volume